| [1]Rodriguez JP， Astudillo P， Rios S， et al.Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis[J].Curr Stem Cell Res Ther,2008,3(3):208-218[2]Sawant A， Chanda D， Isayeva T， et al.Noggin is novel inducer of mesenchymal stem cell adipogenesis: implications for bone health and obesity[J].J Biol Chem,2012,287(15):12241-12249[3]Tuljapurkar SR， McGuire TR， Brusnahan SK， et al.Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging[J].J Anat,2011,219(5):574-581[4]Cohen A， Dempster DW， Stein EM， et al.Increased marrow adiposity in premenopausal women with idiopathic osteoporosis[J].J Clin Endocrinol Metab,2012,97(8):2782-2791[5]Faje A， Klibanski A.Body composition and skeletal health: too heavyToo thin[J].? Curr Osteoporos Rep,2012,10(3):208-216[6]Gimble JM， Nuttall ME.The relationship between adipose t12 and bone metabolism[J].Clin Biochem,2012,45(12):874-879[7]Kawai M， Rosen CJ.PPARγ: a circadian transcription factor in adipogenesis and osteogenesis[J].Nat Rev Endocrinol,2010,6(11):629-636[8]Rayalam S， Yang JY， Della-Fera MA， et al.Novel molecular targets for prevention of obesity and osteoporosis[J].J Nutr Biochem,2011,22(12):1099-1104[9]Shen CL， Chyu MC， Yeh JK， et al.Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial[J].Osteoporos Int,2012,23(5):1541-1552[10]Shen CL， Yeh JK， Cao JJ， et al.Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats[J].Osteoporos Int,2010,21(11):1841-1852[11]van den Bergh JP， van Geel TA， Geusens PP.Osteoporosis， frailty and fracture: implications for case finding and therapy[J].Nat Rev Rheumatol,2012,8(3):163-172[12]Marie PJ， Kassem M.Osteoblasts in osteoporosis: past， emerging， and future anabolic targets[J].Eur J Endocrinol,2011,165(1):1-10[13]Mitchner NA， Harris ST.Current and emerging therapies for osteoporosis[J].J Fam Pract,2009,58(7 Suppl Osteoporosis):S45-49[14]Deal C.Potential new drug targets for osteoporosis[J].Nat Clin Pract Rheumatol,2009,5(1):20-27[15]Sebastian T， Johnson PF.Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPβ[J].Cell Cycle,2006,5(9):953-957[16]Zhao QH， Wang SG， Liu SX， et al.PPARγ forms a bridge between DNA methylation and histone acetylation at the C/EBPα gene promoter to regulate the balance between osteogenesis and adipogenesis of bone marrow stromal cells[J].FEBS J,2013,280(22):5801-5814[17]Ahmadian M， Suh JM， Hah N， et al.PPARγ signalling and metabolism: the good， the bad and the future[J].Nat Med,2013,19(5):557-566[18]Moroni L， Fornasari PM.Human mesenchymal stem cells: a bank perspective on the isolation， characterization and potential of alternative sources for the regeneration of musculoskeletal t4s[J].J Cell Physiol,2013,228(4):680-687 |
